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Abstract
Cellular response to environmental challenges requires immediate and precise regulation of
transcriptional programs. During viral infections, this includes the expression of antiviral
genes that are essential to combat the pathogen. Transcribed mRNAs are bound and
escorted to the cytoplasm by the cap-binding complex (CBC). We recently identified a pro-
tein complex consisting of NCBP1 and NCBP3 that, under physiological conditions, has
redundant function to the canonical CBC, consisting of NCBP1 and NCBP2. Here, we pro-
vide evidence that NCBP3 is essential to mount a precise and appropriate antiviral
response. Ncbp3-deficient cells allow higher virus growth and elicit a reduced antiviral
response, a defect happening on post-transcriptional level. Ncbp3-deficient mice suffered
from severe lung pathology and increased morbidity after influenza A virus challenge. While
NCBP3 appeared to be particularly important during viral infections, it may be more broadly
involved to ensure proper protein expression.
Author summary
Infection with viruses and other pathogens requires appropriate cellular countermeasures,
which involve swift and accurate adaptation of gene expression profiles. mRNAs encoding
for immune-regulatory and effector proteins need to be transported into the cytoplasm in
order to generate proteins necessary to fight the pathogen. Here we show that this process
requires proper functionality of the Nuclear cap protein 3 (NCBP3), a protein recently
identified to contribute to an alternative mRNA cap-binding complex. An Ncbp3-deficient
mouse model allowed higher virus growth in vitro and showed high susceptibility to influ-
enza A virus challenge in vivo. While NCBP3-deficient cells were able to transcriptionally
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upregulate cytokine mRNAs, generation of cytokines was significantly reduced in the
absence of NCBP3. Our data shows a non-redundant function of NCBP3 and the alterna-
tive cap-binding complex in antiviral responses. More broadly, this work demonstrates a
yet unappreciated aspect of post-transcriptional gene regulation.
Introduction
Successful control of virus infections requires immediate and appropriate response to invading
pathogens, a process coordinated by the innate immune system. The activation of the innate
immune system is predominantly initiated by viral nucleic acids that are delivered into the cell
during the infection process and bear virus-specific chemical or structural signatures [1]. Path-
ogen-associated molecular patterns (PAMPs) are sensed by specific pattern recognition recep-
tors (PRRs), which activate signaling cascades leading to transcription of antiviral defense
genes. This includes antiviral and inflammatory cytokines such as type I interferons (IFN-α/
β), tumor necrosis factor alpha (TNF-α) and interleukins (IL) including pro-inflammatory IL-
6, IL-8 and IL-12 [2]. Cytokines act in a paracrine and autocrine manner and bind to specific
receptors, which trigger secondary signaling cascades leading to transcriptional activation of
antiviral and inflammatory effector genes. This includes several hundred IFN-stimulated
genes (ISGs) such as interferon-induced proteins with tetratricopeptide repeats (IFITs), ortho-
myxovirus resistance genes (MX) or 2’-5’-oligoadenylate synthases (OAS) [3, 4]. Transcripts
are exported from the nucleus to the cytoplasm and translated into bioactive proteins that
form a large antiviral network [5]. Transcription, mRNA processing, export and translation
are therefore indispensable to effectively counteract virus infection and to mount an appropri-
ate innate immune response.
To protect cellular RNA polymerase II transcripts from degradation and to guide them
through the sequence of steps leading from transcription to translation, the transcripts, includ-
ing messenger RNAs (mRNAs), are co-transcriptionally capped at the 5‘-end by a mono-meth-
ylated guanosine through a 5’-5’ triphosphate linkage (cap) [6]. The RNA cap is bound by the
cap-binding complex (CBC), which coordinates RNA processing, export and initiation of
translation. The CBC is a heterodimeric complex consisting of nuclear cap binding protein 1
(NCBP1) and NCBP2 [7]. While NCBP2 directly binds the cap, NCBP1 allows recruitment of
cellular factors required for subsequent mRNA maturation [6, 7, 8]. After capping, RNA mole-
cules undergo a series of modifications, most notably splicing and 3‘-end polyadenylation,
which are tightly controlled by multiple protein complexes. It was shown that accurate mRNA
processing allows its association to the export receptor NXF1-NXT1 (TAP-p15) and is a pre-
requisite for efficient export through the nuclear pore complex (NPC) [9].
We recently identified an alternative CBC consisting of the cap-binding protein NCBP3
and NCBP1 [10]. Under physiological conditions the canonical and alternative CBCs show a
high degree of functional redundancy in facilitating export of RNA polymerase II transcripts,
with the alternative CBC showing increased affinity to mRNA than to the other types of RNA.
We have previously shown that under physiological conditions, depletion of either NCBP2 or
NCBP3 does not affect cell viability, while depletion of both cap-binding proteins leads to
reduced cell growth. Similarly, only co-depletion of NCBP2 and -3 or the sole common
adapter NCBP1 retains polyadenylated RNA in the nucleus. Why eukaryotes evolved two
CBCs, consisting of distinct cap-binding proteins bound to a common adaptor, remained
unclear. We speculated that the alternative CBC may be particularly important in situations of
cellular stress such as during virus infections.
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Viruses have identified mRNA processing as a primary target for downregulating immune
responses and supporting viral replication and spread. Influenza A virus (IAV), for instance,
encodes the nonstructural protein 1 (NS1) to counteract and downregulate host innate
immune responses, in part through targeting multiple steps in the mRNA processing and
nuclear export [11, 12]: (I) IAV-NS1 blocks RNA 3‘-end processing through inhibiting compo-
nents of the cleavage and polyadenylation specificity factor (CPSF) complex. (II) IAV-NS1
binds directly to PABPN and thereby pertains proper mRNA polyadenylation and transport to
the cytoplasm. (III) IAV-NS1 associates to the export receptor NXF1-NXT1 and the nuclear
pore protein NUP98. Another example of mRNA export manipulation is the vesicular stomati-
tis virus (VSV) matrix protein (M), which attaches to the RNA binding protein RAE1 and pre-
vents its interaction with nucleoporin NUP98, leading to accumulation of mRNA and small
nuclear RNA (snRNA) in the nucleus [12]. Impaired mRNA processing and export inhibit
appropriate immune responses and therefore paralyze cells in a vulnerable state. Conversely,
mutations in IAV-NS1 or VSV-M proteins lead to attenuation of these virus strains and even
allow their usage as safe therapeutic agents [13, 14].
The recently identified alternative CBC consisting of NCBP1 and NCBP3 under physiologi-
cal conditions functions in a redundant manner to the canonical CBC consisting of NCBP1
and NCBP2. However, NCBP3 was required to limit virus growth in vitro. The functional basis
for this phenomenon remained unclear as well as its relevance for the immune response in
vivo. Here, we show that NCBP3 is required to facilitate translation of cytokine mRNA into
functional proteins and to mount a proper immune response during virus infections in vitro.
Genetic depletion of Ncbp3 in vivo rendered mice susceptible to IAV infection, indicating a
critical role of NCBP3 during antiviral responses in vivo.
Results
Generation and characterization of Ncbp3 knockout mice
To test the function of NCBP3 in vivo, we generated Ncbp3 knockout (ko) mice from embry-
onic stem cells with an inserted knockout cassette in the Ncbp3 gene locus (S1A Fig). Correct
insertion of the knockout cassette was confirmed by gene-specific PCR assays and resulted in
49% of heterozygous F0 mice (S1A and S1B Fig). Heterozygous Ncbp3 knockout mice
(Ncbp3+/-) showed no phenotype as compared to littermate controls. However, when breeding
Ncbp3+/- mice we obtained reduced numbers of Ncbp3-deficient (Ncbp3-/-) offspring (Fig 1A,
S1D Fig). Similarly, reduced number of homozygous mice was obtained upon breeding
Ncbp3-/- to heterozygous animals (Fig 1A). Born Ncbp3-/- mice showed reduced body weight
compared to littermate controls but no other obvious phenotype during an observation period
of 14 months (S1E and S1F Fig). Tissues of 12–13 weeks-old mice were analyzed for Ncbp3
promoter activity by quantifying LacZ expression under the control of the endogenous Ncbp3
gene regulatory elements (Fig 1B). Moderate expression was observed in bone marrow, pan-
creas, spleen, thymus, sexual organs, kidney, and liver, high expression in lungs and brain, and
highest expression in heart and muscle, with minor differences between male and female
animals.
Ncbp3 wild-type (Ncbp3+/+) and Ncbp3-/- mouse embryonic fibroblasts (MEFs) isolated
from heterozygous crossings were morphologically similar. Loss of Ncbp3 was confirmed by
western blot analysis employing a NCBP3-specific antibody (Fig 1C). Heterozygous MEFs
showed intermediate expression of NCBP3. We proceeded to use these cells to investigate the
function of the alternative CBC in vitro. To test whether the canonical CBC is operative in
murine cells, we employed a transient knockdown experiment depleting NCBP1 and NCBP2
by siRNA. Knockdown efficiency was confirmed by western blot analysis (Fig 1D). In line with
Function of the alternative cap-binding complex in innate immunity
PLOS Pathogens | https://doi.org/10.1371/journal.ppat.1008155 December 19, 2019 3 / 22
results in human cells [10], NCBP2 depletion did not affect growth of Ncbp3+/+ MEFs com-
pared to control siRNA treatment (Fig 1E). In contrast, knockdown of NCBP2 significantly
reduced growth of Ncbp3-/- MEFs. This effect was comparable to reduction of cell growth after
NCBP1 depletion. These experiments indicate that the function of the canonical CBC
(NCBP1- NCBP2) and the alternative CBC (NCBP1- NCBP3) is conserved in murine and
human cells. It also supports the notion that the two CBCs duplicate the function of each other
under normal physiological conditions.
Fig 1. Characterization of Ncbp3 knockout mice. (A) Mendelian frequency of Ncbp3 tm1a crossings. Expected and obtained Mendelian ratios
of F1 Ncbp3 tm1a crosses are presented. (B) Expression of Ncbp3 in different tissues. Tissues from 3 animals per genotype and gender were
isolated and individual and mean values ± SD normalized to background signal are presented. (C) Western blot analysis of Ncbp3 tm1a MEFs.
MEFs were generated from Ncbp3 wild-type (wt; Ncbp3+/+, tm1a-/-), heterozygous (het; Ncbp3+/-, tm1a+/-) and knockout (ko; Ncbp3-/-, tm1a+/+)
embryos and western blot analysis was performed using antibodies against indicated proteins. (D) Knockdown efficiency of NCBP1 and NCBP2
was confirmed by western blot, staining with antibodies against indicated proteins. (E) Cell growth of Ncbp3+/+and Ncbp3-/- MEFs after RNAi-
mediated knockdown. MEFs were electroporated twice with siRNAs against Ncbp1, Ncbp2 or non-targeting siRNA (siCtrl). Cell viability was
measured as described in Materials and Methods at indicated time points. RNAi treatment was performed in triplicates and the graph displays
the mean ± SD. NCBP1/2/3, Nuclear cap-binding protein 1/2/3; wt, wild-type; het, heterozygous; ko, knockout; RLU, relative light units.
https://doi.org/10.1371/journal.ppat.1008155.g001
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Loss of NCBP3 increases RNA virus replication in vitro
A phenotype of NCBP3 depletion was previously shown to become apparent under challenging
environmental conditions [10]. We employed viral infection, a highly stressful condition requir-
ing a prompt cellular response, to test for the specific role of NCBP3. To this aim we selected
influenza A virus (IAV) and vesicular stomatitis virus (VSV), which replicate in the nucleus and
cytoplasm, respectively. In addition, we used viral mutants that lost their ability to efficiently
inhibit the innate immune response (IAV-ΔNS1, VSV-M2). Notably, infection with different
doses of an IAV reporter virus expressing renilla luciferase showed that Ncbp3-/- MEFs allowed
increased IAV-renilla reporter activity as compared to Ncbp3+/+ MEFs (Fig 2A). We reconsti-
tuted Ncbp3-/- MEFs with control or Ncbp3-encoding lentiviruses that allow doxycycline-depen-
dent transgene induction. Transient expression of NCBP3 in Ncbp3-/- MEFs reduced IAV-
renilla reporter activity to similar extent as seen when comparing Ncbp3 wt and -ko MEFs (Fig
2A–2C), confirming a direct effect of Ncbp3. To further corroborate the increased susceptibility
of Ncbp3-/- MEFs towards IAV, we infected cells with IAV-wt and quantified infectious viral
particles in the supernatants. Ncbp3-/- MEFs produced 30-fold more infectious IAV particles
compared to Ncbp3+/+ controls (Fig 2D). The IFN-inducing variant IAV-ΔNS1 also grew to
over 10-fold higher titers in Ncbp3-/- as compared to Ncbp3+/+ MEFs (Fig 2D).
In order to further corroborate observed increased susceptibility of Ncbp3-/- MEFs towards
IAV, we performed western blots to analyze viral protein accumulation and explored the acti-
vation of antiviral response in terms of expression of interferon inducible protein IFIT1. In
line with a role in virus growth regulation, accumulation of the viral nucleoprotein (NP) and
non-structural protein 1 (NS1) was increased in Ncbp3-/- MEFs as compared to Ncbp3+/+
counterparts (Fig 2E). Despite the higher accumulation of viral proteins, expression of IFIT1
in response to virus infection was similar for both genotypes (Fig 2E). The discrepancy
between viral and IFIT1 protein abundance was especially apparent upon infection with IAV-
ΔNS1. This phenotype is not in line with an expected correlation between the levels of viral
and antiviral defense proteins and is suggestive for an involvement of NCBP3 in mounting an
appropriate immune response.
Similar results were obtained when assessing the abundance of viral RNA in infected cells.
IAV RNA was present at 10-fold higher levels in Ncbp3-/- MEFs as compared to wild-type con-
trols (Fig 2F). Higher accumulation of viral mRNA was accompanied by higher interferon beta
(Ifnb1) and tumor necrosis factor (Tnf) mRNA levels in Ncbp3 ko cells as compared to wt con-
trols, indicating proper activation of interferon regulatory factor (IRF) and nuclear factor
kappa B (NF-κB) signaling in Ncbp3 ko cells (Fig 2F). Surprisingly, despite higher viral and
Ifnb1 mRNA expression in Ncbp3-deficient as compared to wt MEFs, accumulation of inter-
feron-induced Ifit1 and Ifit3 mRNA was comparable in both cell types (Fig 2F), further indica-
tive of the imbalance in induction of an antiviral response in Ncbp3 ko MEFs. RNA of the
housekeeping gene Hmbs was similarly expressed upon infection and in Ncbp3-ko compared
to wt cells (Fig 2F), supporting our previous observations that generic mRNA maturation is
not affected by the absence of NCBP3.
In order to further study viral activation of innate immune pathways potentially dependent
on Ncbp3, we quantified amounts of secreted IRF- and NF-κB-regulated cytokines IP-10 and
IL-6 upon infection of MEFs with IAV-ΔNS1. IP-10 secretion was not significantly different
between Ncbp3+/+ and Ncbp3-/- MEFs (Fig 2G), further corroborating the lack of ISG response
of appropriate magnitude relative to viral replication levels (Fig 2D). Interestingly, IL-6 secre-
tion was significantly attenuated in Ncbp3 ko as compared to wt MEFs (Fig 2G), highlighting
an imbalance between NF-κB signaling pathway activation and corresponding cytokine secre-
tion in Ncbp3 ko MEFs.
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In sum, these experiments indicate that NCBP3 is required to control IAV infection in
vitro. Despite significantly higher accumulation of viral proteins and viral nucleic acids in
Ncbp3-/- cells, the induction of cytokines and antiviral response genes was equal or even
reduced in Ncbp3-ko MEFs as compared to wt controls, indicating a potential inability to
mount an appropriate innate immune response in the absence of NCBP3.
To exclude that the effect of NCBP3 depletion is specific to IAV, we also tested growth of
VSV, a virus that replicates in the cytoplasm. In line with data obtained for IAV, VSV-driven
luciferase signal was increased in Ncbp3-/- MEFs as compared to wt controls (Fig 3A). Accu-
mulation of infectious virus in supernatants of Ncbp3-/- relative to Ncbp3+/+ MEFs was
100-fold increased for VSV-wt as well as the interferon-inducing variant VSV-M2 (Fig 3B).
Notably, despite the significantly increased virus growth, expression of IFIT1 protein was
again similar in Ncbp3-wt and -ko MEFs (Fig 3C). These results indicate that Ncbp3-deficient
MEFs cannot support an innate immune response to an extent required to cope with the
increased viral load. Altogether, these data show that infection with unrelated RNA viruses,
regardless of their replication site, results in higher accumulation of viral particles in superna-
tant of NCBP3-depleted cells. Activation of the innate immune responses is similar in Ncbp3-
wt and -ko MEFs but execution of the innate immune response was impaired in Ncbp3-
depleted cells.
Global proteomic analysis suggests altered innate immune response of a
subset of ISGs in Ncbp3-deficient MEFs
Our data indicate that Ncbp3-wt and -ko MEFs differ in their ability to translate innate
immune signals into adequate response on the level of mRNA and proteins. In order to inves-
tigate this defect on a proteome-wide scale we performed proteomic analysis of IAV-infected
MEFs. Briefly, MEFs were infected with IAV-wt for 24 hours and total viral and host protein
expression was analyzed by liquid chromatography coupled to tandem mass spectrometry
(LC-MS/MS) (Fig 4A). This analysis allowed quantification of 5422 proteins in Ncbp3+/+ and
Ncbp3-/- MEFs (S1 Table). In line with the increased virus growth, we could observe increased
expression of viral proteins in Ncbp3-deficient as compared to wt MEFs (Fig 4B). Despite
increased accumulation of viral proteins, bulk ISG-expression was reduced upon IAV infec-
tion of Ncbp3-/- MEFs compared to Ncbp3+/+ controls as seen by a significant distribution shift
towards lower induction, which is specific to ISGs and not observed for the total proteome
(Fig 4C). Overall, we have identified 282 proteins that change their response to IAV infection
upon NCBP3 knockout, including 19 ISGs (Fig 4D, S1 Table). In order to extract functional
Fig 2. Loss of NCBP3 supports increased IAV replication in vitro. (A) Luciferase activity in lysate of Ncbp3 wt and ko MEFs upon infection at different MOIs. MEFs
were infected with an IAV-wt reporter virus (strain SC35M) expressing renilla luciferase using indicated MOIs for 21 hours. Luminescence counts were normalized to
total protein concentration. Graphs display the mean ± SD of virus infections performed in triplicates. (B) Relative luciferase activity in lysate of Ncbp3 ko MEFs
transduced with doxycycline-inducible Ncbp3 or no-transgene (Ctr) encoding lentiviruses and infected with IAV-renilla reporter virus for 21 hours. Graph displays
mean ± SD of three measurements. Representative of three independent repeats is shown. Rec. gene, reconstituted gene, n.s. P>0.05, �� P<0.01 as analyzed by two-tailed
equal variance t-test. (C) Induction of reconstituted gene was confirmed by western blot using antibodies against indicated proteins. (D) Accumulation of infectious viral
particles in supernatants of IAV-infected MEFs quantified by TCID50. MEFs were infected with IAV-wt and -ΔNS1 (strain SC35M) using an MOI of 0.01 and 0.1,
respectively, for 24 hours. ��� P<0.001 as analyzed by two-way analysis of variance (ANOVA) with Bonferroni‘s p-value correction. (E) Western blot analysis of IAV-
infected Ncbp3 wt and ko MEFs using antibodies against indicated proteins. MOI, multiplicity of infection; IAV, Influenza A virus; IFIT1, Interferon-induced protein with
tetratricopeptide repeats 1; IAV-NP, Influenza A virus nucleoprotein; IAV-NS1, Influenza A virus non-structural protein 1. (F) mRNA expression of indicated genes in
IAV-infected Ncbp3 wt and ko MEFs. MEFs were infected with indicated MOIs of IAV-wt and -ΔNS1 for 24 hours and transcript abundance analyzed by qRT-PCR. Data
were normalized to murine Tbp mRNA. The mean of two technical replicates of a representative of four separate infection experiments is shown. N.s. P>0.05, � P<0.05, ��
P<0.01, ��� P<0.001 as analyzed by two-tailed equal variance t-test. IAV-M, Influenza A virus matrix protein; Ifnb1, Interferon beta; Tnf, tumor necrosis factor; Hmbs,
hydroxymethylbilane synthase; ND, not detected. (G) Concentrations of secreted cytokines in MEFs infected with IAV-ΔNS1 at an MOI of 0.1 for 24 hours as determined
by ELISA against indicated proteins. Graph displays mean ± SD of three separate infection experiments. N.s. P>0.05, �� P<0.01 as determined by two-tailed equal
variance t-test.
https://doi.org/10.1371/journal.ppat.1008155.g002
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information from observed changes of protein abundances, we performed GO-term enrich-
ment analysis on differentially expressed proteins (S2 Table). Top 10 terms enriched in pro-
teins upregulated upon infection were related to antiviral responses. However, the numbers of
proteins associated to individual terms as well as enrichment probability was lower in case of
Ncbp3-ko MEFs despite overall higher number of differentially expressed proteins (Fig 4E).
Among the 19 ISGs, differentially regulated between Ncbp3-wt and -ko MEFs upon infection,
four types of expression changes could be observed (Fig 4D, green dots, Fig 4F): (I) ISGs that
were up-regulated in wt cells after virus infection but showed reduced response in Ncbp3-ko:
Bst2, Irgm2 and Rtp4; (II) ISGs that lost their up-regulation in Ncbp3-ko: Ctnna2, H2-K1,
Ifi44, Irgm1, Lgals3bp, Timp2, Ube2l6 and Usp18; (III) ISGs that were up-regulated in wt cells,
but became slightly down regulated in Ncbp3-ko cells: Helz2 and Tspo; and (IV) ISGs not
affected by infection in wt cells and slightly down-regulated in Ncbp3-ko cells: Lipa, Gla,
Crabp2 and Tor1aip2. Only one ISG, Noc4l, was found to be exclusively upregulated in
Ncbp3-ko upon IAV infection and not in wt cells. Collectively, these results showed that the
induction of ISGs is reduced in the absence of NCBP3, potentially explaining its influence on
virus growth.
NCBP3 is required for cytokine induction and response in vitro
Viral infection experiments suggested regulation of innate immune-response genes in an
Ncbp3-dependent manner. These results prompted us to test MEFs for their ability to respond
to the synthetic dsRNA analogue and potent innate immune stimulator polyinosinic-polycy-
tidylic acid (PIC). Remarkably, compared to wt MEFs, PIC-treated Ncbp3-deficient cells
showed significantly reduced accumulation of IL6 in the supernatants (Fig 5A). This difference
was particularly apparent when low amounts of PIC were used and was additionally observed
for the NF-κB-induced cytokine RANTES (CCL5) (Fig 5B). Intriguingly, despite significant
differences in IL-6 accumulation in the supernatant, Il6 mRNA expression was similar in both
wt and Ncbp3-ko MEFs (Fig 5C). These data suggest that cytokine expression requires a
Fig 3. Loss of NCBP3 supports increased VSV replication in vitro. (A) Luciferase activity in lysate of Ncbp3 wt and ko MEFs upon infection at
different MOIs. MEFs were infected with a VSV-wt reporter virus expressing firefly luciferase using indicated MOIs for 21 hours. Luminescence
counts were normalized to total protein concentration. Graphs display the mean ± SD of virus infections performed in triplicates. (B) Viral particle
accumulation in supernatants of VSV-infected MEFs quantified by TCID50. MEFs were infected with VSV-wt and -M2 using an MOI of 0.001 for 24
hours. ��� P<0.001 as analyzed by two-way analysis of variance (ANOVA) with Bonferroni‘s p-value correction. (C) Western blot analysis of VSV-
infected Ncbp3 wt and ko MEFs using antibodies against indicated proteins. MOI, multiplicity of infection; VSV, Vesicular stomatitis virus; VSV-G,
Vesicular stomatitis virus glycoprotein; Ifit1, Interferon-induced protein with tetratricopeptide repeats 1; Ncbp3, Nuclear cap-binding protein 3.
https://doi.org/10.1371/journal.ppat.1008155.g003
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Fig 4. Global proteomic analyses suggest differential expression of a subset of ISGs. (A) Design of proteomic experiment. Ncbp3 wt and ko MEFs were infected for 24
hours with IAV-wt (strain SC35M, MOI 0.1). Cells were lysed and proteomic changes were analyzed by shotgun liquid chromatography-tandem MS (LC-MS/MS). (B)
Viral proteins expression in infected MEFs of the indicated genotype. Log2-transformed non-imputed LFQ intensities are shown for each individual replicate. Grey color
denotes missing values (ND). (C) Density of log2 fold change distribution for all quantified proteins (top) or ISGs (bottom) upon IAV infection of Ncbp3-wt (blue) and
-ko (red) MEFs. P-values were calculated using two-sided Kolmogorov-Smirnov test. (D) Differential expression of host proteins between IAV-infected and mock
conditions in Ncbp3 wt (X axis) and Ncbp3 ko (Y axis) MEFs. Proteins exhibiting a significant differential response between the cell lines are highlighted in green (ISGs)
or blue (non-ISGs). ISGs that were significantly changing either in Ncbp3 ko or wt upon infection but do not show significantly different response between Ncbp3 ko and
wt are highlighted in pink. (E) GO-term analysis of up-regulated host proteins upon infection of Ncbp3 wt and ko MEFs. Numbers of up-regulated proteins is indicated in
Venn diagram (top), and top 10 GO-terms ordered by enrichment p-value for infection of Ncbp3 wt MEFs are shown (bottom). Color of cells correspond to enrichment
p-values as indicated in legend and indices in cells correspond to number of protein groups associated to individual GO-terms in respective comparison. (F) Z-scored
expression levels of significantly differentially regulated ISGs between infected and mock conditions for Ncbp3-ko and–wt MEFs. Grey color represents missing values
(ND).
https://doi.org/10.1371/journal.ppat.1008155.g004
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Fig 5. Ncbp3 depletion alters innate immune responses. (A-C) Concentration of secreted IL6 and RANTES for Ncbp3 wt and ko MEFs. MEFs were electroporated with
0.15 (A), 0.5 and 0.05 (B) and 0.125 (C, D) μg/mL PIC and cytokine concentrations in supernatants determined 3, 8 and 24 hours (A) or 24 hours (B) after stimulation by
enzyme-linked immunosorbent assay (ELISA). Data represent the individual and the mean value ± SD of PIC treatments performed in triplicates. N.s. P>0.05, ���
P<0.001 as analyzed by two-way analysis of variance (ANOVA) statistics with Bonferroni‘s post-test. (C) Il6 mRNA expression in PIC treated Ncbp3 wt and ko MEFs.
MEFs were stimulated with PIC for 16 hours and Il6 mRNA abundance evaluated by qRT-PCR. Data were normalized to murine Actb mRNA and the mean ± SD of three
biological replicates consisting of three technical replicates are represented. N.s., P>0.05 as analyzed by two-tailed paired sample t-test. (D) Antiviral gene mRNA
expression levels in Ncbp3 wt and ko MEFs, electroporated with 0 (mock) or 0.125 μg/mL PIC. Data represent the mean ± SD values of three biological replicates of
stimulation performed in triplicates. � P<0.05, �� P<0.01, ��� P<0.001 as analyzed by two-tailed paired sample t-test. Ifit1, Interferon-induced protein with
tetratricopeptide repeats 1; Ifit3, Interferon-induced protein with tetratricopeptide repeats 3; Oas1a, 2’-5’-Oligoadenylate Synthetase 1. (E) IFIT1 expression in Ncbp3 wt
and ko MEFs stimulated with IFN. Ncbp3 wt and ko MEFs were treated with IFN-αB/D for 18 hours. IFIT1 expression was determined by western blot analysis.
Depletion of Ncbp3 and equal loading was confirmed by western blotting against indicated proteins. IL6, interleukin 6; PIC, Polyinosinic:polycytidylic acid; IFN,
interferon; NCBP3, Nuclear cap-binding protein 3; IFIT1, Interferon-induced protein with tetratricopeptide repeats 1.
https://doi.org/10.1371/journal.ppat.1008155.g005
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functional alternative CBC that operates on a post-transcriptional level. By extending the rep-
ertoire of quantified transcripts, we additionally noticed a clear trend towards lower expression
of hallmark ISGs Ifit1, Ifit3 and Oas1a in Ncbp3 ko MEFs upon treatment with PIC (Fig 5D).
To test whether NCBP3 is also required to properly execute an interferon response we stimu-
lated MEFs with IFN-αB/D and tested for their ability to synthesize the antiviral protein IFIT1
by western blot analysis. In the absence of NCBP3, IFN-αB/D elicited IFIT1 levels were clearly
reduced as compared to those in wt MEFs (Fig 5E). This difference was again particularly evi-
dent at low cytokine concentrations and less prominent when high amounts of IFN-α were
used for stimulation of cells. Taken together, these data indicated that NCBP3 plays a major
role in mounting an antiviral state in response to viral infection, stimulation with a synthetic
PRR ligand or treatment with type I interferon and is required for a full-scale antiviral immune
response in vitro.
Ncbp3 deficiency results in increased IAV-induced mortality in vivo
Lack of NCBP3 leads to increased virus growth, mitigated cytokine response and reduced
induction of a subset of ISGs in vitro. To test the relevance of NCBP3 in vivo, we infected
Ncbp3-ko and littermate control mice intranasally with a sublethal dose of IAV. IAV primarily
infects the pulmonary epithelium, which exhibits high expression of NCBP3 relative to other
tissues (Fig 1B). As expected, control mice survived virus challenge. However, IAV infection
resulted in high mortality of Ncbp3-deficient mice of which 66.7% had to be euthanized for
animal welfare reasons within 13 days of infection (Fig 6A). Histological analysis of IAV-
infected wt and Ncbp3-ko mice revealed differences in IAV-induced lung pathology between
the two genotypes. Ncbp3-ko mice showed increased lung inflammatory cell recruitment and
pathology characterized by severe epithelial damage and infiltration of lymphocytes, hallmarks
of necrotic peribronchial pneumonia caused by influenza A virus infection (Fig 6B and 6C).
Collectively, these experiments show that NCBP3 is required to control virus growth and to
mount adequate innate immune responses in vitro and that loss of NCBP3 results in severe
virus-induced inflammation and pathology in vivo that correlates with decreased survival.
Discussion
Regulation of gene expression is one of the most fundamental processes in cellular organisms.
To obtain functional proteins, the genetic information has to be transcribed into mRNA and
shuttle between the nucleus and the cytoplasm. Coordination of this event is fundamental for
precise gene expression in a timely manner. Under challenging conditions such as virus infec-
tions, proper functioning of the mRNA processing machinery becomes even more important
since an immediate and adequate response needs to be executed. We previously identified
human NCBP3 as a cap-binding protein assembling the alternative CBC together with NCBP1
that is involved in the export of polyadenylated RNA from the nucleus in a similar manner as
the canonical CBC under physiological conditions [10]. Here, we show that Ncbp3-deficient
mice are viable, which supports our in vitro finding that NCBP3 is dispensable under physio-
logical conditions since it exhibits redundant functions to NCBP2. Surprisingly, breeding of
Ncbp3 heterozygous or knockout mice revealed an atypical Mendelian ratio of born knockout
animals suggesting that NCBP3 is required for proper embryonic development, which may be
a consequence of its involvement in tightly regulated gene transcription programs that are par-
ticularly important during embryogenesis [15].
The alternative CBC is required to respond to specific environmental cues and to allow
appropriate gene expression [10], which is critical in coordination of the antiviral response
triggered by virus infections [16, 17]. In vitro, infections with RNA viruses resulted in elevated
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Fig 6. NCBP3 is required to defend IAV infection in vivo. (A) Survival of Ncbp3-wt and -ko mice after infection with IAV-wt
(strain SC35M). Mice (n = 9 per group) were infected intranasally with 1,500 PFU of IAV and survival was monitored over 13
days. (B) Histological sections of lungs from IAV-wt infected Ncbp3-wt and -ko mice. Mice (n = 5 per group) were infected with
1,500 PFU of IAV for 7 days and paraffin-embedded sections were stained with hematoxylin and eosin. Representative images
are shown in 5x (left panel) and 20x (right panel) magnification. Exemplar regions exhibiting prominent lymphocyte infiltration
are highlighted (black arrowheads). Scale bar represents 50 μm. (C) Cell infiltration score in Ncbp3-wt and -ko lung tissue. Lung
sections of 7 days IAV-infected mice (n = 5 per group) were scored for severity of cell infiltration (0–5). Data represent the
individual and the mean values ± SD of infiltration scores. � P<0.05 as analyzed by one-way analysis of variance (ANOVA) with
non-parametric Kruskal-Wallis statistics and Dunn‘s post-test.
https://doi.org/10.1371/journal.ppat.1008155.g006
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viral titers, increased viral protein production as well as in higher viral transcript expression in
Ncbp3-deficient cells. Since this was observed both for nuclear- and cytoplasmic-replicating
viruses, the effect of NCBP3 appears to rather be on the regulation of antiviral immune
responses than a direct interference with viral RNA export and growth. Given the high abun-
dance of viral transcripts and proteins in Ncbp3-deficient cells, expression of ISGs, monitored
by Ifit1 and Ifit3 mRNA, IFIT1 protein and secreted cytokines IP-10 and IL-6, did not scale
with the severity of stimulus. This indicates a dysregulation of the normal procession of innate
immune response in Ncbp3-deficient cells and a general inability of Ncbp3-ko cells to translate
a stimulatory trigger into protective antiviral immunity. Proteomic analyses of IAV-infected
Ncbp3-ko and wt MEFs showed reduced expression of a subset of ISGs in Ncbp3-deficient
cells, including antiviral restriction factors as well as negative regulators of type I interferon,
additionally supporting the requirement of NCBP3 for an appropriate antiviral response. Con-
solidating our data, NCBP3 was necessary for proper expression of antiviral proteins such as
IFIT proteins and BST2 (also known as Tetherin), which are antiviral factors active against a
wide variety of viruses [3, 18, 19]. While IFIT proteins are nucleic acid-binding proteins that
restrict virus replication, BST2 impairs the release of enveloped viruses including IAV and
VSV. The impaired induction of restriction factors, such as IFIT proteins and BST2, could
explain the higher viral load and elevated accumulation of viral particles in the supernatants of
Ncbp3-ko compared to wt cells. Similarly, Ncbp3-ko MEFs showed reduced expression of
USP18 and UBE216, which are involved in ISGylation induced by innate responses. During
IAV infection, NS1 is ISGylated which leads to inhibition of viral replication [3, 20, 21]. Alter-
ation in ISGylation in the absence of NCBP3 could therefore further contribute to enhanced
viral replication. In sum, our results indicate defects in the induction of an appropriate antivi-
ral immune response in Ncbp3-ko cells in vitro, which goes in line with higher viral titers.
An involvement of NCBP3 in induction of antiviral immune responses was further sup-
ported by stimulation experiments using the synthetic dsRNA analogue PIC and recombinant
IFN-αB/D Ncbp3-deficient cells showed significantly reduced secretion of pro-inflammatory
cytokines IL-6 and RANTES, as well as expression of key ISG IFIT1, particularly when stimu-
lated with low concentrations of ligands. However, at higher concentrations of stimuli, the
dependency on NCBP3 gradually decreased. This suggests that when sufficiently high amounts
of mRNA are produced, dependency on NCBP3 is alleviated and it is no longer a bottleneck in
antiviral protein production. The exact molecular mechanisms of NCBP3 involvement in the
antiviral response remain to be elucidated. NCBP3 was previously shown to be sufficient to
alleviate the mRNA-export defect induced by depletion of NCBP2 under physiological condi-
tions [10]. The absence of NCBP3 may slow down or reduce the throughput of nuclear to cyto-
plasm export of specific antiviral transcripts, such as Il6 mRNA, which could additionally
impact the transcripts stability. This theory may explain the reduced post-transcriptional exe-
cution of innate immune response observed in NCBP3-deficient cells. Alternatively, cap-inde-
pendent interactions of NCBP3 with constituents of the mRNA maturation machinery,
including the canonical CBC, were recently observed in vitro, which could independently or
synergistically contribute to the observed phenotype [22]. Such a function of NCBP3 would be
predominantly important in the early stages of infection in vivo, when little virus stimulus trig-
gers an antiviral response, and unimpaired execution of antiviral programs is required to con-
trol initial infection. The exact timing of antiviral responses is of central importance to control
virus infection and can dramatically affect the outcome of a disease [23]. Therefore, a fully
functional mRNA processing system may be required to allow tight regulation of a rapid
response.
In an organism, the antiviral program needs to be strictly coordinated to effectively prevent
viral spread and associated pathologies [24, 25]. While timely expression of cytokines and
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antiviral proteins is crucial at early stages of infection, expression of negative regulators is
essential to prevent overshooting immune reactions after successful virus clearance [16, 26, 27,
28]. This highly dynamic and regulated expression may require the alternative CBC.
Material and Methods
Reagents
Hybrid human IFN-αB/D [29], which is highly active on mouse cells, was used for this study.
Polyinosinic-polycytidylic acid (PIC; Sigma Aldrich; P9582) and siRNAs (Dharmacon) were
transfected into cells using Neon Transfection System (Invitrogen). Primary antibodies were
used according to manufacturer recommendation and were as follows: NCBP1 (Thermo
Fisher Scientific, PA5-30098), NCBP3 (Atlas Antibodies; HPA008959), Histone H3 (Abcam;
ab1791–100). For viral protein detection, we used antibodies against IAV (Millipore; AB1074)
and VSV-G (Santa Cruz; sc-66180). Antibodies against NCBP2 were purified from serum of
rabbits immunized with recombinant full-length protein purified from E. coli. Serum isolated
from Ifit1-deficient mice immunized with full-length murine IFIT1 protein purified from E.
coli was used to detect IFIT1. Antibodies against β-Actin (Santa Cruz; sc-47778) and secondary
antibodies detecting mouse (Dako), rabbit (Sigma-Aldrich), goat (Santa Cruz) IgG were horse-
radish peroxidase-coupled. CellTiter-Glo Luminescent Cell Viability Assay kit was purchased
from Promega. Interleukin-6 was measured by enzyme-linked immunosorbent assay (ELISA)
obtained from R&D Systems. Mass spectrometry grade trypsin and LysC was obtained from
Wako Chemicals USA and Sigma-Aldrich, respectively. pLIX403 was a gift from David Root
(Addgene plasmid # 41395).
Viruses
All used viruses are classified as BSL2 pathogens in Germany and experiments were carried
out according official regulations. Wild-type influenza A virus strain SC35M was used in
mouse experiments. In cell culture experiments, we used wild-type as well as NS1-deleted
influenza A virus strain SC35M [30] and wild-type and M2-mutated (M51R substitution in
M2 protein) vesicular stomatitis virus [31]. IAV-ΔNS1 and VSV-M2 are deficient in their abil-
ity to block innate immune responses due to the lack of NS1 and mutation in M2 protein,
respectively. In addition, we used an IAV-wt reporter virus [32] that expresses renilla luciferase
and a VSV-wt reporter virus expressing firefly luciferase, which were a kind gift from Peter
Reuther and Gert Zimmer, respectively.
Generation of Ncbp3-knockout mice
Genetically modified ES cell clones (JM8.F6; C57BL/6N background) carrying a promotor-less
targeting cassette to generate “knockout-first” allelic mutation were obtained from the Euro-
pean Conditional Mouse Mutagenesis Program (EUCOMM) [33, 34]. The cassette codes for a
neomycin resistance and a LacZ gene with a splice acceptor and a polyA site flanked by FRT
sites. Additionally, the second exon of Ncbp3 is flanked by loxP sites; deletion of exon 2 results
in a frame-shift mutation in the Ncbp3 gene (S1A Fig). Through the insertion of this cassette, a
so-called tm1a mutation is generated resulting in the disruption of the targeted Ncbp3 gene.
Chimeras were generated by ES cell injection into C57BL/6 albino (B6(Cg)-Tyr<c-2J>/J)
blastocyst donors, which were implanted into pseudo-pregnant mice. Germ-line male chime-
ras generated from one ES clone (Ncbp3 clone A06) were bred with C57BL/6 albino females to
produce heterozygous, tm1a-carrying F1 mice (C57BL/6N-Ncbp3tm1a/Mpi). Heterozygous F1
mice carrying the tm1a mutation in one Ncbp3 allele were further bred and maintained in the
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animal facility of the MPI of Biochemistry at SPF (specific pathogen-free) conditions. Body
weight was monitored at weaning (age 19-23 days) and for a group of mice for a period of 13
months. Mouse husbandry was carried out in accordance with animal welfare regulations and
have been approved by the responsible authorities (TVA 55.2-1-54-2532-116-2015).
Genotyping of Ncbp3 tm1a mice
Ncbp3tm1a mice were genotyped using the following primers: Ncbp3_tm1a-fw 5‘-CTGTATG
TCCGGTCGTCATC-‘3, Ncbp3_tm1a-rev 5´-GCCTGCATGTACCATGCATT-‘3. PCR con-
ditions were as followed: (1) 94˚C for 1 minute (1×); (2) 94˚C for 30 sec, 57˚C for 20 sec, 72˚C
for 30 sec (35×). PCR products were visualized using a 1% agarose gel electrophoresis.
LacZ/ß-Galactosidase assay
Ncbp3 expression in tissues was determined by ß-Galactosidase expression driven under
endogenous Ncbp3 promotor from the LacZ gene of the tm1a cassette. Tissues were isolated
from heterozygous (Ncbp3tm1a+/-) and wild-type (background control) mice and homogenized
in 2 μL reaction buffer per 1 mg tissue using SS matrix beads (MP Biomedicals) and the Fas-
tPrep-24 machine with the following setting: 4x 20 seconds, MP, 4 m/s. Lysates were cleared
by centrifugation at 18000x g at 4˚C for 30 minutes. Cleared lysates were used to determine ß-
Galactosidase expression using the FluoReporter lacZ/Galactosidase Quantification kit (Ther-
moFischer Scientific; F-2905) according manufacturer‘s guidelines. The assay was done in a
384-well format, wherefore, half of the manufacturer‘s volumes were used. ß-Galactosidase sig-
nals were first divided by total protein content in the lysate measured using Pierce 660nm Pro-
tein Assay Reagent (ThermoFischer Scientific; 22660) according manufacturer‘s protocol and
then normalized to mean ß-Galactosidase signals in the respective tissue of the same gender.
Isolation and immortalization of mouse embryonic fibroblasts
Mouse embryonic fibroblasts (MEFs) were generated from day 13.5 embryos from heterozy-
gous intercrosses. All following steps were carried out in a tissue culture hood under sterile
conditions. First, uterine horns were dissected out and washed several times in 1x PBS.
Embryos were isolated separately from the placenta and its embryonic sac and placed in sterile
1x PBS. Heads, red organs and extremities were removed from the embryos and the remaining
tissue placed in fresh 1x PBS. Subsequently, the remaining tissue was minced and incubated
for 10 minutes at 37˚C in 3 ml 0.05% trypsin/EDTA (ThermoFischer Scientific). Supernatant
containing single cell suspension was cleaned through a cell strainer (Greiner Bio-One Inter-
national; 542070) adding 30 ml pre-warmed complete DMEM (ThermoFischer Scientific; con-
taining 10% (v/v) fetal bovine serum and antibiotics (100 U/ml penicillin and 100 mg/ml
streptomycin)) and subsequently centrifuged at 1000x g for 5 min. Trypsin treatment was
repeated several times with remaining tissue. Cells were resuspended in 3 ml complete DMEM
and seeded in a cell culture dish. After three passages, the cells were immortalized with
SV40-LT by retroviral infection. Immortalized cells were selected with 3 μg/ml puromycin
(Sigma-Aldrich; P8833) for eight passages and used for further experiments.
RNAi-mediated knockdown and cell growth assay
MEFs were electroporated with duplex siRNAs using the Neon Transfection System (Invitro-
gen) for targeted gene depletion. Duplex siRNAs were obtained from Dharmacon and had the
following sequences: Ncbp1 (#1: 5´-AUGCAGAAAUGGACCGAAU-3‘, #2: 5‘-CGUCUGGA
CACGAUGAGUA-3‘, #3: 5‘-GGUACGAUGUGAAACGGAU-3‘, #4: 5‘-AGGCCUAACACU
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CGCGUUU-3‘), Ncbp2 (#1: 5‘-CAGCAAAAGUGGUGAUAUA-3‘, #2: 5‘-GCAAUGCGGU
ACAUAAACG-3‘, #3: 5‘GUAUGGACGUGGACGGUCU-3‘, #4: 5‘-ACGAGUAUCGGGAG
GACUA-3‘) and scrambled (5‘-AAGGTAATTGCGCGTGCAACT-3‘). Transfection of siRNA
and cell growth assay was previously described elsewhere [10]. Cell growth was analyzed at the
indicated time points after the second/repeated siRNA transfection. For western blot analysis,
cells were lysed in SSB buffer (62.5 mM Tris-HCl pH 6.8, 2% sodium dodecyl sulfate, 10% glyc-
erol, 50 mM dithiothreitol, 0.01% bromophenol blue) and boiled for 10 minutes at 95˚C and
subjected to SDS–polyacrylamide gel electrophoresis and western blot analysis.
Cell growth assays
Cell growth was determined after RNAi-mediated knockdown at indicated time points using
CellTiter-Glo (Promega) according to the manufacturer’s instructions with the modifications
previously described elsewhere [10].
In vitro virus infection
MEFs were seeded on the day before infection and infected with IAV-wt, -ΔNS1 and VSV-wt,
-M2. Duration and multiplicity of infection (MOI) is indicated in the figure legends. Superna-
tants of virus-infected cells were collected and virus titers were quantified by 50% tissue cul-
ture-infective dose (TCID50) assays on Vero E6 (purchased from ATCC, CRL-1586) cells. For
western blot analysis, cells were lysed in RIPA buffer (50 mM Tris-HCl pH 7.5, 150 mM NaCl,
0.25% sodium deoxycholate, 1% NP-40, 1 mM EDTA) and boiled after addition of Laemmli
buffer for 10 minutes at 95˚C and subjected to SDS–polyacrylamide gel electrophoresis and
western blot analysis. For proteomic analysis, cell pellets were snap-frozen in liquid nitrogen
before further processing. For RT-PCR analysis, RNA was isolated using NucleoSpin RNA
Plus kit (Macherey Nagel) or Direct-zol RNA MiniPrep Plus (Zymo Research) according man-
ufacturer‘s protocol.
For luciferase reporter viruses, MEFs were infected with IAV and VSV strains expressing
luciferase with different MOIs (indicated in figures). After 21 hours, cells were lysed in 1x pas-
sive lysis buffer (Promega) and lysates were mixed with equal volume of 2x renilla reagent
solution (100 mM K3PO4, 500 mM NaCl, 1 mM EDTA, 25 mM Thiourea, 30 μM Coelentera-
zine) or 2x firefly reagent solution (20 mM Tris-HCl pH 7.8, 0.1 mM EDTA, 3.74 mM magne-
sium sulfate, 33.3 mM dithiothreitol, 0.27 mM coenzyme A, 0.47 mM D-luciferin, 0.53 mM
adenosine triphosphate) in technical duplicates. Subsequently, luminescence was measured
using an Infinite 200 PRO series micro plate reader (Tecan). Luminescence counts were nor-
malized to total protein concentration measured using Pierce 660nm Protein Assay Reagent
(Thermo Fischer Scientific; 22660).
For reconstitution experiments, Ncbp3-ko MEFs were transduced with either Ncbp3-bear-
ing or empty lentivirus plasmids. In short, HEK293Ts (a gift from Mary Collins, University
College London, UK) grown under standard conditions were transfected with pLIX403-based
plasmids containing transgene under doxycycline inducible promoter together with packaging
plasmids [35]. At six hours post transfection, growth medium was exchanged. Lentivirus-con-
taining medium was harvested 48 hours post transfection and supplemented to target cells. At
24 hours post transduction, the inoculum was aspirated and replenished with fresh medium or
medium containing 1μg/mL doxycycline. Transduced cells were used for further experiments
24 hours post doxycycline induction.
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IFN and PIC treatment
All used concentrations are indicated in figures and figure legends. For IFN treatment, IFN-
αB/D was added to the medium of homogenously attached MEFs in a 24-well format and cells
were further incubated at 37˚C with 5% CO2. Cells were lysed in RIPA buffer (50 mM Tris-
HCl pH 7.5, 150 mM NaCl, 0.25% sodium deoxycholate, 1% NP-40, 1 mM EDTA) and boiled
in Laemmli buffer for 10 minutes at 95˚C and subjected to SDS–polyacrylamide gel electro-
phoresis and western blot analysis. For PIC stimulation, MEFs were transfected using the
Neon Transfection System (Invitrogen) and seeded in 24- or 6-well format. Supernatants were
collected after indicated time points and IL-6 concentration was determined using the mouse
IL6 DuoSet Elisa (R&D systems) or CCL5/RANTES DuoSet Elisa (R&D systems) according
manufacturer‘s instructions. Cells were lysed and RNA was isolated using NucleoSpin RNA
Plus kit (Macherey Nagel) according manufacturer’s instructions.
Quantitative RT-PCR analysis
RNA was reverse transcribed using the PrimeScript RT Reagent Kit with or without gDNA
Eraser (Takara/Clontech) and quantified by quantitative RT-PCR using the QuantiFast SYBR
Green RT-PCR kit (Qiagen) and a CFX96 Touch Real-Time PCR Detection System (Bio-Rad).
Each cycle consisted of 10 seconds at 95˚C and 30 seconds at 60˚C, followed by melting curve
analysis. ΔCt values below -20 were considered below detection range and in corresponding
figures marked with not detected (ND). Primer sequences targeting transcripts, originating
from indicated mouse genes, were as follows: Tbp (5‘-CCTTCACCAATGACTCCTATGAC-
3‘and 5‘-CAAGTTTACAGCCAAGATTCA-3‘), Actb (5‘-CTCTGGCTCCTAGCACCATGA
AGA-3‘and 5‘-GTAAAACGCAGCTCAGTAACAGTCCG-3‘), Hmbs (5‘-GAGTCTAGATG
GCTCAGATAGCATGC-3‘and 5‘-CCTACAGACCAGTTAGCGCACATC-3‘), Ifit1 (5’- GG
CAGGACAATGTGCAAGAA-3’ and 5’- CCATAGCGGAGGTGAATATC-3’), Ifit3 (5‘-TG
GTCATGTGCCGTTACAGG-3‘and 5‘-GCTGCGAGGTCTTCAGACTT-3‘), Ifnb1 (5‘-CG
GAGAAGATGCAGAAGAGT-3‘and 5‘-TCAAGTGGAGAGCAGTTGAG-3‘), Tnf (5’- CA
AAATTCGAGTGACAAGCCTG-3’ and 5’- GAGATCCATGCCGTTGGC-3’), Il6 (5‘-TA
GTCCTTCCTACCCCAATTTCC-3‘and 5‘-TTGGTCCTTAGCCACTCCTTC-3‘), Oas1a (5’-
CTTCCCCAGGGAGGTACATT-3’ and 5’-CTGCATCAGGAGGTGGAGTT-3’), and IAV-M
(5‘-AGATGAGYCTTCTAACCGA-3‘and 5‘-GCAAAGACATCTTCAAGTYTC-3‘).
Quantitative LC-MS/MS-based proteomics
For proteome analysis, four virus infections were performed in parallel. Frozen MEF cell pel-
lets were lysed in U/A buffer (8 M Urea, 100 mM Tris-HCl pH 8.5) shaking for 10 minutes at
RT followed by sonication for 15 minutes using a Bioruptor (Diagenode) sonicator on high
setting with 30 sec on/off cycles. Lysates were reduced with 10 mM dithiothreitol for 30 min-
utes at RT and incubated for 20 minutes with 55 mM iodacetamid in the dark to alkylate pro-
teins. Subsequently, a total of thirty micrograms of proteins were digested with LysC (Wako
Chemicals USA) and trypsin (Sigma-Aldrich), acidified with TFA and desalted with C18 stage
tips. Desalted peptides were analyzed by liquid chromatography coupled to mass spectrometry
on a Q Exactive HF MS system (Thermo Fischer Scientific). Raw MS data were processed with
MaxQuant version 1.5.5.1 [36] using the built-in Andromeda engine to search against mouse
(UniprotKB, mus musculus; Proteome ID UP000000589; release 29/08/2016) and influenza A
virus (UniprotKB, strain A/Seal/Massachusetts/1/1980 H7N7; Proteome ID UP000008576;
release 27/07/2017) protein sequences (the reverse sequences were used as decoy). Label-free
quantification (LFQ) algorithm [37] and Match between Runs option were used with standard
settings.
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LFQ intensities were log2-transformed and missing values imputed from normal distribu-
tion of quantified values using default settings (width of 0.3 and down shift of 1.8). Differential
expression analysis was performed using the limma package in R [38]. To identify the proteins,
whose response to infection altered between Ncbp3-ko and -wt MEFs, the interaction term of
the linear model was used. The criterion for significantly changing proteins was |log2(fold
change)×log10(p value)|>3. ISGs were annotated using the INTERFEROME v2.0 database [39]
filtered for mouse fibroblast cells and a minimal fold change of 2. Graphs were plotted in R
and adapted using Adobe Illustrator. Z-score was calculated using the following formula:
(LFQ(protein)–LFQ(mean of sample)) / sd(sample). Kolmogorov-Smirnov test was performed
using R version 3.5.1. GO-term enrichment analysis was performed on differentially expressed
host proteins using quantifiable proteome as reference dataset on the level of protein groups
using hypergeometric test in R version 3.5.1. GO-terms, associated with more than 2 protein
groups and false discovery rate adjusted p-value below 0.01 were considered significant.
In vivo virus infection
6–8 weeks old mice were anesthetized by intra-peritoneal injection of ketamine (100 μg per
gram body weight) and xylazine (5 μg per gram body weight). The infection was administered
intranasal with 1500 PFU of influenza A virus diluted in 40 μl sterile PBS. Body weight (weight
loss) and survival was monitored for 13 days. Mice with a body weight loss greater than 25% of
the initial weight were sacrificed and recorded as succumbed to infection. For histology of
lung sections, left lobes were isolated from mice, fixed in 4% PFA and embedded in paraffin.
Paraffin-embedded sections were stained with hematoxylin and eosin, and cell infiltration
scores (0-5) were defined for severity of tissue inflammation as described before [40].
Ethics Statement
All experiments with mice were carried out in accordance with the guidelines of the Federation
for Laboratory Animal Science Associations (FELASA) and the national animal welfare body.
Experiments were in compliance with the German animal protection law and were approved
by the animal welfare committee of the Regierungspra¨sidium Freiburg (permit G-12/46).
Supporting information
S1 Fig. Characterization of Ncbp3 knockout mice. (A) Schematic overview of the promoter-
less tm1a cassette inserted in intronic Ncbp3 region. The cassette was inserted into the first
intron of Ncbp3 gene locus (NM_025818.3) flanked by FRT sites and encodes for a neomycin
resistance and a LacZ gene with splice acceptor and a polyA site. Exon 2 is flanked by loxP
sites which, after recombination, results in a frame-shift mutation. (B) Genotyping PCR of
Ncbp3 tm1a mice. PCR amplification results in a 324 bp construct for Ncbp3 wt mice and a
204 bp construct for Ncbp3 ko (tm1a promoterless cassette insertion) mice. (C) Genotypes of
Ncbp3 chimera crossings. Male Ncbp3 chimeras were crossed with C57BL/6 albino and
obtained genotypes are represented. (D) Genotypes of Ncbp3 tm1a crossings. Ncbp3 tm1a
mice were bred to homogeneity and genotypes obtained for the indicated breeding combina-
tion are shown. (E) Body weights of Ncbp3 wt and ko mice at the age of weaning. Body weight
of 52 animals per genotype in the age of 19-23 days were monitored. ��� P<0.001 as analyzed
by one-way analysis of variance (ANOVA) statistics with Bonferroni‘s post-test. (F) Body
weight development of Ncbp3 wt and ko mice over 13 months. Body weight of 6 animals per
genotype and gender were monitored for 13 months. FRT, Flipase Recognition Target; EnS
2A, splice acceptor site; T2A, peptide sequence with self-cleaving function; lacZ, lacZ gene
encoding for ß-galactosidase; neo, neomycin resistance gene; pA, simian virus 40
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polyadenylation signal; loxP, locus of X-over P1; bp, base pair; wt, wild-type; ko, knockout;
Ncbp3, Nuclear cap-binding protein 3.
(TIF)
S1 Table. Quantitative proteomics after IAV infection in Ncbp3 wt and ko MEFs. Ncbp3
wt and ko MEFs were infected for 24 hours with Influenza A virus (SC35M; MOI 0.1). Proteo-
mic changes were analyzed by quantitative proteomics (see Fig 4 and Methods). Table contains
non-imputed label-free quantification (LFQ) intensities of all identified proteins, fold change
differences, p-values and pi-scores (pi = -log10(p-value)�logFC) from the linear model com-
paring infection vs mock for Ncbp3 wt and ko. Interaction fold changes, p-values and pi-scores
comparing changes in Ncbp3 wt and ko during infection are depicted as well. Interaction sig-
nificance is classified into the following categories: (1) sig: proteins showing significant differ-
ential regulation between Ncbp3 ko and wt in infection, (2) sig ISG: ISGs with differential
regulation between Ncbp3 ko and wt in infection, (3) non-sig: no differential regulation in
infection between Ncbp3 ko and wt (4) non-sig ISGs: ISGs with no differential regulation in
infection between Ncbp3 ko and wt, but regulated in at least one of the two genotypes between
infection and mock (5) viral: viral proteins.
(XLSX)
S2 Table. GO-terms, enriched for differentially regulated proteins upon infection of MEFs
with IAV. Results of GO-term enrichment of host proteins, significantly changed upon infec-
tion of Ncbp3 wt or Ncbp3 ko MEFs or differentially regulated between the infections.
Table contains significant GO terms (go_id and go_name), numbers of protein groups associ-
ated to go terms in selected comparisons or quantifiable dataset (subset and reference_set,
respectively), p-values and false discovery rate adjusted p-values (p and p.adj, respectively),
enrichment of proteins associated to GO-term in the subset (enrichment), name of gene ontol-
ogy (go_name), Ncbp3 genotype of comparison (Ncbp3 genotype) and mode denoting
whether GO-term is associated to either up- or down-regulateed proteins in specific compari-
son. Analysis was performed as described in materials and methods. In short, GO-term was
considered significant if number of protein groups associated to it in differentially regulated
subset is above 2 and adjusted p value below 0.01.
(XLSX)
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